en

PRODUCT DETAIL

Rapamune 2 mg obalené tablety

Code 40690
MA number EU/1/01/171/009
Product Form: tbl obd 30x2 mg (blis.PVC/PE/Aclar/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA10 Sirolimus
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 13.03.2001
SmPC + PL: European Medicines Agency's database
Dokument: Rapamune II94 DHPC-sk-clean-day+25.pdf  
Safety feature Yes
Data update: 08.02.2023
eu-flag.png sk-flag.png